TSS
CGEM icon

Two Sigma Securities’s Cullinan Oncology CGEM Stock Holding History

Two Sigma Securities’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
+15,220
New +$226K 0.02% 926
2022
Q3 		– Sell
-24,640
Closed -$316K – 2646
2022
Q2 		$316K Buy
+24,640
New +$279K 0.01% 1254

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Two Sigma Securities's CGEM Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Cullinan Oncology (CGEM) in Q2 2026: 15,220 shares worth $277K. The stake represents 0.02% of the portfolio and ranks #926 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in CGEM as recently as Q2 2022.

Two Sigma Securities first reported a position in CGEM in Q2 2022 and has held it in 2 quarters since. The position peaked at $316K in Q2 2022. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Two Sigma Securities held 15,220 shares of Cullinan Oncology worth $277K as of Q2 2026.
  • Cullinan Oncology was a new Two Sigma Securities position in Q2 2026.
  • Cullinan Oncology made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #926 holding.
  • Two Sigma Securities first reported a position in Cullinan Oncology in Q2 2022 and has held it in 2 quarters since.
  • Two Sigma Securities's Cullinan Oncology position peaked at $316K in Q2 2022.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.